Bottom line
How much do BBH and HTEC overlap?
24% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 31.7% of BBH's assets and 13.8% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.
HTEC holds far more positions (63 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and HTEC have in common
| Holding | % of BBH | % of HTEC | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | 9.10% | 1.91% | 1.91% |
| Regeneron Pharmaceuticals Inc | 6.21% | 1.97% | 1.97% |
| Natera Inc | 4.92% | 2.23% | 2.23% |
| IQVIA Holdings Inc | 4.31% | 2.10% | 2.10% |
| Illumina Inc | 3.17% | 2.09% | 2.09% |
| Incyte Corp | 2.49% | 1.80% | 1.80% |
| Charles River Laboratories International Inc | 1.50% | 1.71% | 1.50% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
- Moderna Inc — 3.36%
- United Therapeutics Corp — 2.83%
- BeOne Medicines Ltd — 2.81%
- Insmed Inc — 2.67%
- Neurocrine Biosciences Inc — 2.08%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Bio-Techne Corp — 1.54%
- BioMarin Pharmaceutical Inc — 1.34%
Only in HTEC
- Caredx, Inc. — 2.68%
- Guardant Health, Inc. — 2.31%
- Twist Bioscience Corp — 2.23%
- Thermo Fisher Scientific Incorporated — 2.18%
- Medpace Holdings, Inc. — 2.12%
- Adaptive Biotechnologies Corporation — 2.11%
- Arrowhead Pharmaceuticals, Inc. — 2.08%
- Glaukos Corporation — 1.92%
- Stryker Corporation — 1.91%
- Livanova Plc — 1.87%
- Siemens Healthineers AG — 1.85%
- Lonza Group AG — 1.85%
- Abbott Laboratories — 1.79%
- AxoGen, Inc. — 1.77%
- Boston Scientific Corporation — 1.73%
Asset mix
| Asset type | BBH | HTEC |
|---|---|---|
| Stocks | 100.0% | 99.8% |
| Cash & short-term funds | 0.1% | 0.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | BBH | HTEC |
|---|---|---|
| US | 87.3% | 82.9% |
| NL | 6.0% | 1.6% |
| CH | 2.8% | 5.0% |
| HK | — | 3.7% |
| DE | 1.9% | 1.9% |
| IE | 1.9% | — |
| FR | — | 1.6% |
| IT | — | 1.3% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do BBH and HTEC overlap?
What stocks do BBH and HTEC have in common?
Should I own both BBH and HTEC?
Which holds more stocks, BBH or HTEC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.